NEU 0.06% $15.61 neuren pharmaceuticals limited

Possibly a new direction?, page-26

  1. 141 Posts.
    lightbulb Created with Sketch. 130
    They must demonstrate the ability to manufacture and distribute the drug or the FDA just won't approve it. It's as simple as that.

    Jon said at the AGM the 2591 commercial product is being made now and will be ready for phase 3 trials. He also said the gap between phase 2 and 3 trials will be much shorter than for Daybue and proceedings will start after the terms are determined with the FDA in this quarter's meeting.

    In my opinion, Neuren is prepared for any eventuality whether it be your suggestion or a takeover.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$15.61
Change
0.010(0.06%)
Mkt cap ! $1.995B
Open High Low Value Volume
$15.64 $15.93 $15.44 $8.412M 538.2K

Buyers (Bids)

No. Vol. Price($)
1 558 $15.59
 

Sellers (Offers)

Price($) Vol. No.
$15.66 1841 1
View Market Depth
Last trade - 16.10pm 15/08/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.